---
title: "Sex differences in antibody breadth and memory after seasonal H3N2 influenza vaccination"
id: "medrxiv-14-broader-functional-and-memory-antibody-responses-in-adult-females-than-males-in"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-14-broader-functional-and-memory-antibody-responses-in-adult-females-than-males-in"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.17.26368332v1?rss=1"
published_at: "2026-11-19T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Sex differences in antibody breadth and memory after seasonal H3N2 influenza vaccination
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-14-broader-functional-and-memory-antibody-responses-in-adult-females-than-males-in
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.17.26368332v1?rss=1)
- **Published At:** 2026-11-19T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Cohort: healthcare workers aged 21–48 years (mean 31 years) provided plasma at 0, 28, and 180 days post-vaccination during the 2022–2023 influenza season. - Investigators measured responses to the three vaccine strains: **A/H3N2**, A/H1N1, and B/Victoria. - Females mounted greater **A/H3N2 neutralizing antibody** (nAb) responses than males through 180 days post-vaccination (DPV); this sex difference was not observed for A/H1N1 or B/Victoria. - The largest nAb differences appeared among A/H3N2 responders defined by ≥4-fold rises in titer. - Memory B cells from female responders secreted more IgG after ex vivo H3 stimulation at both 28 and 180 DPV compared with males. - Before vaccination, female responders already had higher anti-H3 IgG and greater binding to FcγRIIB (CD32b); those elevated responses persisted through 180 DPV. - Female responders showed greater H3-specific antibody-dependent monocyte phagocytosis (ADMP) and antibody-dependent natural killer cell (ADNK) secretion of IFNγ and CCL4, both pre- and post-vaccination. - ADMP correlated with sustained H3N2 neutralization through 180 DPV in females only, linking a functional Fc-mediated assay to durable nAb in that sex. - The study team observed that the durability of ADMP, ADNK, and nAb in females versus males largely explained the sex-specific differences in vaccine-induced immunity. - Authors propose that higher pre-vaccination **FcγR**-binding antibodies in females might contribute to longer-lived neutralizing and non-neutralizing responses, with potential relevance for next-generation influenza vaccines. - Data access is restricted by Johns Hopkins IRB; the report is a medRxiv preprint and has not undergone peer review.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=lTErh67mvuCvcZPGVZCHlKm4g27dCqQaaVHEJR8N124-1795144165.95644-1.2.1.1-ZOlYZawqfeN_Lu49Ei3zg7yZNO34gOMSEYKBJ8V52y5UjDM8w4Ih9qREDSrnAI7a) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.17.26368332v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Broader functional and memory antibody responses in adult females than males in response to seasonal H3N2 vaccine virus [ View ORCID Profile](http://orcid.org/0000-0003-3778-5481)Han-Sol Park, [ View ORCID Profile](http://orcid.org/0000-0002-1612-5532)Anna Yin, [ View ORCID Profile](http://orcid.org/0000-0002-1442-7633)Maclaine A. Parish, Jingping Hu, Ainslee Zou, Rishi Pandey, Katherine Z.J. Fenstermacher, Richard E. Rothman, [ View ORCID Profile](http://orcid.org/0000-0003-3248-1761)Andrew Pekosz, Franklin R. Toapanta, [ View ORCID Profile](http://orcid.org/0000-0002-0730-5224)Sabra Klein doi: https://doi.org/10.64898/2026.11.17.26368332 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Han-Sol Park 1 W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Han-Sol%2BPark%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Park%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHan-Sol%2BPark%2B) * [ORCID record for Han-Sol Park](http://orcid.org/0000-0003-3778-5481 "Open in new tab") Anna Yin 2 Johns Hopkins University Bloomberg School of Public Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Anna%2BYin%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Yin%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAnna%2BYin%2B) * [ORCID record for Anna Yin](http://orcid.org/0000-0002-1612-5532 "Open in new tab") Maclaine A. Parish 1 W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Maclaine%2BA.%2BParish%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Parish%20MA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMaclaine%2BA.%2BParish%2B) * [ORCID record for Maclaine A. Parish](http://orcid.org/0000-0002-1442-7633 "Open in new tab") Jingping Hu 3 Center for Vaccine Development and Global Health, University of Maryland School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jingping%2BHu%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hu%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJingping%2BHu%2B) Ainslee Zou 1 W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ainslee%2BZou%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Zou%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAinslee%2BZou%2B) Rishi Pandey 1 W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Rishi%2BPandey%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Pandey%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARishi%2BPandey%2B) Katherine Z.J. Fenstermacher 4 Department of Emergency Medicine, The Johns Hopkins School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Katherine%2BZ.J.%2BFenstermacher%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Fenstermacher%20KZ&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AKatherine%2BZ.J.%2BFenstermacher%2B) Richard E. Rothman 4 Department of Emergency Medicine, The Johns Hopkins School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Richard%2BE.%2BRothman%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Rothman%20RE&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARichard%2BE.%2BRothman%2B) Andrew Pekosz 5 Johns Hopkins Bloomberg School of Public Health * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Andrew%2BPekosz%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Pekosz%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAndrew%2BPekosz%2B) * [ORCID record for Andrew Pekosz](http://orcid.org/0000-0003-3248-1761 "Open in new tab") Franklin R. Toapanta 3 Center for Vaccine Development and Global Health, University of Maryland School of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Franklin%2BR.%2BToapanta%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Toapanta%20FR&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AFranklin%2BR.%2BToapanta%2B) Sabra Klein 1 W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sabra%2BKlein%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Klein%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASabra%2BKlein%2B) * [ORCID record for Sabra Klein](http://orcid.org/0000-0002-0730-5224 "Open in new tab") * For correspondence: sklein2@jhu.edu * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.17.26368332v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1349164/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.17.26368332v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1349164/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.17.26368332v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1349164/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.11.17.26368332v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1349164/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.17.26368332v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1349164/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.17.26368332v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1349164/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Females of reproductive ages often mount greater antibody responses than males following influenza vaccination, but the breadth and depth of these differences, including antibody-dependent Fc receptor (FcR)-mediated functions have not been explored. Plasma samples were collected from male and female healthcare workers (range of 21-48y; mean of 31y) at 0, 28, and 180 days post-vaccination (DPV) during the 2022-2023 influenza vaccine season to assess antibody responses to A/H1N1, A/H3N2, and B/Victoria vaccine viruses. Females had greater A/H3N2, but not A/H1N1 or B/Victoria, neutralizing antibody (nAb) responses compared to males through 180 DPV, with differences being most pronounced among A/H3N2 responders (≥4 fold-change in nAb titers). Memory B cells isolated from female responders secreted more IgG in response to ex vivo H3 stimulation than those from males at 28 and 180 DPV. Before vaccination, female responders had greater anti-H3 IgG responses and FcγRIIB (CD32b) antibody binding than males, with females maintaining greater responses through 180 DPV. Female responders had greater H3-specific antibody-dependent monocyte phagocytosis (ADMP) and natural killer cell (ADNK) secretion of IFNγ and CCL4 prior to and after vaccination, with ADMP positively correlating with greater H3N2 neutralization through 180 DPV in females only. Among responders, the durability of ADMP, ADNK, and nAb in females as compared to males defined the sex differences in influenza-vaccine induced immunity. The greater FcγR-binding antibodies prior to vaccination in females might improve the durability of both neutralizing and non-neutralizing antibody responses to diverse vaccines, including next generation influenza vaccines. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Johns Hopkins Institutional Review Boards (IRB00091667) gave ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The clinical data and specimens used in this study are from the Johns Hopkins Health System (JHHS). These individual-level patient data are protected for privacy. Qualified researchers affiliated with Johns Hopkins University (JHU) may apply for access through the Johns Hopkins Institutional Review Board (IRB; https://www.hopkinsmedicine.org/institutional_review_board/). Those not affiliated with JHU seeking to collaborate may contact the corresponding author. The datasets generated and/or analyzed during the current study are not publicly available due to IRB restrictions but are available from the corresponding author on reasonable request. Data in figures can be found at Vivli (link pending). All code can be accessed through GitHub at https://github.com/ayin0510/JHU85-2022-2023-Influneza-Vaccine-Responses-in-HCWs. ## Funder Information Declared National Institutes of Health NIAID Johns Hopkins Center of Excellence for Influenza Research and Response, 75N93021C00045, T32AI007417 Cooperative Center for Human Immunology (CCHI), U19AI181108, 000540061-SC007 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.17.26368332v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.17.26368325v1 "Complementary DNA-contact and domain-destabilizing mechanisms of PAX9 and MSX1 variants in non-syndromic tooth agenesis: an AlphaFold 3, ThermoMPNN, and AlphaGenome study") Posted November 19, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.17.26368332v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/19/2026.11.17.26368332.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.17.26368332v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.11.17.26368332v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/19/2026.11.17.26368332.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Broader functional and memory antibody responses in adult females than males in response to seasonal H3N2 vaccine virus Han-Sol Park, Anna Yin, Maclaine A. Parish, Jingping Hu, Ainslee Zou, Rishi Pandey, Katherine Z.J. Fenstermacher, Richard E. Rothman, Andrew Pekosz, Franklin R. Toapanta, Sabra Klein medRxiv 2026.11.17.26368332; doi: https://doi.org/10.64898/2026.11.17.26368332 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368332v1%26text%3DBroader%2520functional%2520and%2520memory%2520antibody%2520responses%2520in%2520adult%2520females%2520than%2520males%2520in%2520response%2520to%2520seasonal%2520H3N2%2520vaccine%2520virus "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368332v1%26t%3DBroader%2520functional%2520and%2520memory%2520antibody%2520responses%2520in%2520adult%2520females%2520than%2520males%2520in%2520response%2520to%2520seasonal%2520H3N2%2520vaccine%2520virus "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368332v1%26title%3DBroader%2520functional%2520and%2520memory%2520antibody%2520responses%2520in%2520adult%2520females%2520than%2520males%2520in%2520response%2520to%2520seasonal%2520H3N2%2520vaccine%2520virus%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368332v1%26title%3DBroader%2520functional%2520and%2520memory%2520antibody%2520responses%2520in%2520adult%2520females%2520than%2520males%2520in%2520response%2520to%2520seasonal%2520H3N2%2520vaccine%2520virus "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.17.26368332) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.11.17.26368332v1&count=horizontal&via=&text=Broader%20functional%20and%20memory%20antibody%20responses%20in%20adult%20females%20than%20males%20in%20response%20to%20seasonal%20H3N2%20vaccine%20virus&counturl=www.medrxiv.org/content/10.64898/2026.11.17.26368332v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (642) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (925) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (355) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5050) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (432) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (681) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1703) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16334) * [Forensic Medicine](https://www.medrxiv.org/collection/foren
## Related Clinical Research

- [Influenza and Coronavirus: Comparative Evolution, Epidemiology, Antivirals, and Vaccines](https://medichelpline.com/clinical-feed/pubmed-43058094.md) (DOI: 10.1038/s41392-026-03078-5)
- [Donor-Derived Ehrlichia ewingii Infection After Pediatric Liver Transplant, US 2023](https://medichelpline.com/clinical-feed/cdc-emerging-infectious-diseases-journal-1-transplant-associated-ehrlichia-ewingii-infection-in-pediatric-liver-recipient.md)
- [Borrelia duttonii: agent of African tick‑borne relapsing fever](https://medichelpline.com/clinical-feed/cdc-emerging-infectious-diseases-journal-0-borrelia-duttonii.md)
- [US Influenza Activity 2025–26: Early A(H3N2) Peak, Two Waves, and Pediatric Burden](https://medichelpline.com/clinical-feed/medrxiv-4-influenza-activity-in-the-united-states-during-the-2025-26-influenza-season.md)
- [Ontario TB Presentations Rose During the Pandemic Era but Not After Community SARS-CoV-2 Activity](https://medichelpline.com/clinical-feed/medrxiv-10-rising-tuberculosis-presentations-in-ontario-canada-are-not-explained-by.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.